Maternal MTR gene polymorphisms and their interactions with periconceptional folic acid supplementation in relation to offspring ventricular septal defects
RUAN Xiao-Rui, SUN Meng-Ting, WEI Jian-Hui, LUO Man-Jun, LIU Han-Jun, TANG Jia-Peng, LI Liu-Xuan, QIN Jia-Bi
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha 410013China
Abstract:Objective To investigate how maternal MTR gene polymorphisms and their interactions with periconceptional folic acid supplementation are associated with the incidence of ventricular septal defects (VSD) in offspring. Methods A case-control study was conducted, recruiting 426 mothers of infants with VSD under one year old and 740 mothers of age-matched healthy infants. A questionnaire survey collected data on maternal exposures, and blood samples were analyzed for genetic polymorphisms. Multivariable logistic regression analysis and inverse probability of treatment weighting were used to analyze the associations between genetic loci and VSD. Crossover analysis and logistic regression were utilized to examine the additive and multiplicative interactions between the loci and folic acid intake. Results The CT and TT genotypes of the maternal MTR gene at rs6668344 increased the susceptibility of offspring to VSD (P<0.05). The GC and CC genotypes at rs3768139, AG and GG at rs1050993, AT and TT at rs4659743, GG at rs3768142, and GT and TT at rs3820571 were associated with a decreased risk of VSD (P<0.05). The variations at rs6668344 demonstrated an antagonistic multiplicative interaction with folic acid supplementation in relation to VSD (P<0.05). Conclusions Maternal MTR gene polymorphisms significantly correlate with the incidence of VSD in offspring. Mothers with variations at rs6668344 can decrease the susceptibility to VSD in their offspring by supplementing with folic acid during the periconceptional period, suggesting the importance of periconceptional folic acid supplementation in genetically at-risk populations to prevent VSD in offspring.
RUAN Xiao-Rui,SUN Meng-Ting,WEI Jian-Hui et al. Maternal MTR gene polymorphisms and their interactions with periconceptional folic acid supplementation in relation to offspring ventricular septal defects[J]. CJCP, 2024, 26(9): 899-906.
GBD 2017 Congenital Heart Disease Collaborators. Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet Child Adolesc Health, 2020, 4(3): 185-200. PMID: 31978374. PMCID: PMC7645774. DOI: 10.1016/S2352-4642(19)30402-X.
Lopez L, Houyel L, Colan SD, et al. Classification of ventricular septal defects for the Eleventh Iteration of the International Classification of Diseases—striving for consensus: a report from the International Society for Nomenclature of Paediatric and Congenital Heart Disease[J]. Ann Thorac Surg, 2018, 106(5): 1578-1589. PMID: 30031844. DOI: 10.1016/j.athoracsur.2018.06.020.
Li X, Li S, Mu D, et al. The association between periconceptional folic acid supplementation and congenital heart defects: a case-control study in China[J]. Prev Med (Baltim), 2013, 56(6): 385-389. PMID: 23480969. DOI: 10.1016/j.ypmed.2013.02.019.
Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid[J]. Proc Natl Acad Sci U S A, 1996, 93(26): 15227-15232. PMID: 8986792. PMCID: PMC26385. DOI: 10.1073/pnas.93.26.15227.
Raina JK, Panjaliya RK, Dogra V, et al. "Association of MTHFR and MS/MTR gene polymorphisms with congenital heart defects in North Indian population (Jammu and Kashmir): a case-control study encompassing meta-analysis and trial sequential analysis"[J]. BMC Pediatr, 2022, 22(1): 223. PMID: 35468734. PMCID: PMC9036697. DOI: 10.1186/s12887-022-03227-z.
Li WX, Dai SX, Zheng JJ, et al. Homocysteine metabolism gene polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) jointly elevate the risk of folate deficiency[J]. Nutrients, 2015, 7(8): 6670-6687. PMID: 26266420. PMCID: PMC4555142. DOI: 10.3390/nu7085303.
Deng C, Deng Y, Xie L, et al. Genetic polymorphisms in MTR are associated with non-syndromic congenital heart disease from a family-based case-control study in the Chinese population[J]. Sci Rep, 2019, 9(1): 5065. PMID: 30911047. PMCID: PMC6433945. DOI: 10.1038/s41598-019-41641-z.
Zhao JY, Qiao B, Duan WY, et al. Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations[J]. Eur Heart J, 2014, 35(11): 733-742. PMID: 23798577. DOI: 10.1093/eurheartj/eht221.
Menezo Y, Elder K, Clement A, et al. Folic acid, folinic acid, 5 methyl tetrahydrofolate supplementation for mutations that affect epigenesis through the folate and one-carbon cycles[J]. Biomolecules, 2022, 12(2): 197. PMID: 35204698. PMCID: PMC8961567. DOI: 10.3390/biom12020197.